Lipoprotein composition in children and adolescents with type 1 diabetes mellitus

J Pediatr Endocrinol Metab. 2005 Mar;18(3):257-64. doi: 10.1515/jpem.2005.18.3.257.

Abstract

Atherosclerotic cardiovascular diseases are the major causes of morbidity and mortality in patients with diabetes mellitus. Both quantitative and qualitative abnormalities of lipo-proteins are associated with the development of atherogenesis. In this study, the prevalence of dyslipidemia and the relative levels of glycosylated lipoproteins in 20 children and adolescents with type 1 diabetes mellitus were determined. Lipid profile, apolipoproteins A-I and B, Lp(a) and LpA-I in plasma were assayed. LpB and glycosylated HDL and LDL were evaluated by ELISA. Diabetic patients and controls had normal lipid profiles, but the diabetic group showed significantly higher LpA-I and lower LpA-I:A-II concentrations than controls. The diabetic group showed a significantly higher glycosylation level of HDL than controls and did not show a statistical difference for glycosylated LDL. No significant correlation between glycosylated lipoproteins, glycemia or HbA1c was found. In conclusion, these results suggest that type 1 diabetic patients develop important qualitative lipid abnormalities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Arteriosclerosis / epidemiology
  • Arteriosclerosis / physiopathology
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / physiopathology
  • Case-Control Studies
  • Child
  • Cholesterol, LDL / blood
  • Diabetes Mellitus, Type 1 / complications*
  • Female
  • Glycosylation
  • Humans
  • Hyperlipidemias / epidemiology*
  • Hyperlipidemias / etiology*
  • Lipoproteins / blood*
  • Lipoproteins / metabolism*
  • Male
  • Prevalence

Substances

  • Cholesterol, LDL
  • Lipoproteins